1)Liotta LA : Tumor invasion and metastases ─role of the extracellular matrix. Cancer Res 46 : 1─7, 1986
2)済木育夫 : 癌転移成立とLiotta仮説.癌転移─基礎と臨床アップデート.日本臨床61(増刊号) : 17─23,2003
3)Normanno N, De Luca A, Bianco C, et al : Epidermal growth factor receptor(EGFR)signaling in cancer. Gene 366 : 2─16, 2006
4)Matsuo M, Sakurai H, Saiki I : ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model. Mol Cancer Ther 2 : 557─561, 2003
5)Müller─Tidow C, Diederichs S, Bulk E, et al : Identification of metastasis─associated receptor tyrosine kinases in non─small cell lung cancer. Cancer Res 65 : 1778─1782, 2005
6)Arteaga CL : HER3 and mutant EGFR meet MET. Nature Med 13 : 675 ─ 677, 2007
7)義江 修 : ケモカインスーパーファミリーの構造と機能.ケモカインハンドブック(義江修他編).秀潤社,東京,p10─19,2000
8)Müller A, Homey B, Soto H, et al : Involvement of chemokine receptors in breast cancer metastasis. Nature 410 : 50─56, 2001
9)Yasumoto K, Koizumi K, Kawashima A, et al : Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66 : 2181─2187, 2006
10)Paget S : The distribution of secondary growths in cancer of the breast. Lancet I : 571─573, 1889
11)Kaplan RN, Rafii S, Lyden D : Preparing the“soil” : the premetastatic niche. Cancer Res 66 : 11089─11093, 2006
12)Hiratsuka S, Nakamura K, Iwai S, et al : MMP9 induction by vascular endothelial growth factor receptor─1 is involved in lung─specific metastasis. Cancer Cell 2 : 289─300, 2002
13)Hiratsuka S, Watanabe A, Aburatani H, et al : Tumour─mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8 : 1369─1375, 2006